Janus Henderson Group PLC Arrowhead Pharmaceuticals, Inc. Transaction History

Janus Henderson Group PLC

$178 Billion
Q1 2024

A detailed history of Janus Henderson Group PLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 57,449 shares of ARWR stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,449

Previous 47,367 21.28%

Holding current value

$1.44 Million

Previous $1.45 Million 13.39%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$27.21 - $39.48 $274,331 - $398,037	10,082 Added 21.28%	57,449 $1.64 Million
Q4 2023 Feb 14, 2024	SELL	$21.2 - $31.03 $1,929 - $2,823	-91 Reduced 0.19%	47,367 $1.45 Million
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $131 - $180	5 Added 0.01%	47,458 $1.28 Million
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $15 Million - $24.6 Million	-594,604 Reduced 92.61%	47,453 $1.69 Million
Q1 2023 May 15, 2023	BUY	$23.68 - $38.51 $1.8 Million - $2.93 Million	76,149 Added 13.46%	642,057 $16.3 Million

Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $93,100 - $134,862	-3,325 Reduced 0.58%	565,908 $23 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $65,097 - $106,137	-2,197 Reduced 0.38%	569,233 $18.8 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $4.45 Million - $8.1 Million	-160,134 Reduced 21.89%	571,430 $20.1 Million
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $9.32 Million - $16.5 Million	-235,121 Reduced 24.32%	731,564 $33.6 Million
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $374,854 - $532,437	6,453 Added 0.67%	966,685 $64.1 Million
Q3 2021 Nov 16, 2021	SELL	$58.38 - $84.96 $10.6 Million - $15.4 Million	-181,363 Reduced 15.89%	960,232 $59.9 Million
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $79,676 - $115,790	1,282 Added 0.11%	1,141,595 $94.5 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $314,725 - $464,111	-5,130 Reduced 0.45%	1,140,313 $75.6 Million
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $570,492 - $1.11 Million	-13,019 Reduced 1.12%	1,145,443 $87.9 Million
Q3 2020 Nov 16, 2020	BUY	$33.21 - $51.27 $7.66 Million - $11.8 Million	230,663 Added 24.86%	1,158,462 $49.9 Million
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $24.2 Million - $40.1 Million	927,799 New	927,799 $40.1 Million

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.65B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Arrowhead Pharmaceuticals, Inc. Transaction History